Capital built for critical technology.
Conviction / Craft / Endurance
One convergence — biotechnology, microelectronics, and robotics — is defining national security. Proving Ground Capital (PGC), the commercial arm of the Applied Research Institute, is positioned ahead of the market: technology and commercialization advisory today, curated investment access as milestones are met.
About Proving Ground Capital (PGC)
Public investment built the foundation. Private capital must help scale what comes next.
Critical technologies often stall between research validation and commercial growth. Proving Ground Capital (PGC) helps companies navigate that gap through commercialization expertise, technical insight, strategic connections, and — as milestones are met — access to aligned capital.
Our focus spans biotechnology, microelectronics, robotics, and autonomy — including the technologies emerging where these sectors converge.
From ARI to Proving Ground Capital (PGC)
ARI built the ecosystem. Proving Ground Capital (PGC) helps capitalize what comes next.
ARI
Applied Research Institute
Backbone operator and ecosystem integrator of a CHIPS Act hub — convening government, universities, industry, and startups around the federal mission.
PGC
Proving Ground Capital
ARI’s wholly owned commercial arm, operated at arm’s length — extending the ecosystem into the commercial market through advisory today and curated investment vehicles as milestones are met.
Why Proving Ground Capital (PGC)
Our edge is structural access — not capital.
Proving Ground Capital (PGC) is built inside an established national innovation ecosystem, with earlier visibility into research-validated, government-aligned technologies.
01
Backbone of a CHIPS Act hub
ARI is the backbone operator and ecosystem integrator of a CHIPS Act hub — convening government, universities, industry, and startups.
02
A network money can’t buy
NSWC Crane, Purdue, Notre Dame, Pentagon program offices, and a growing member base of startups and primes.
03
Deal flow others never see
Research-validated, government-aligned technologies surface inside the ecosystem long before open market processes.
04
Federal direction at our back
Federal partners direct CHIPS hubs to build commercial sustainability alongside the federal mission.
Values
Patient capital, practical partnership.
Invest with discipline and strategic purpose, concentrating on critical technologies where patient capital can make the greatest difference.
Conviction
Pair capital with practical partnership, helping strong ideas cross the commercialization gap with rigor, clarity, and care.
Craft
Take a long-term view, supporting durable companies and U.S. and allied technological leadership.
Endurance
Operating Model
Two phases. One compounding track record.
Milestone-gated, not calendar-gated: track record before discretion, discretion before third-party capital.
Phase 1 · Crawl
Technology & Commercialization Advisory
- Fee-for-service advisory for critical-technology companies and ecosystem members.
- Builds operating revenue, client relationships, and an auditable institutional track record.
- Deliberately scoped: no investment authority in Phase 1.
Phase 2 · Walk
SPV Investment Strategy
- The bridge: Proving Ground Capital (PGC) recommends, ARI deploys from its own balance sheet — a track record without third-party capital.
- Then deal-by-deal SPVs at the bio × micro × robotics convergence.
- An independent Investment Committee holds exclusive investment authority.
Wayfinding
Two ways to engage.
For Companies — Now
Advisory engagements, open today.
Scope a technology roadmap, commercialization pathway, or technical diligence engagement with the team closest to the ecosystem.
For Investors — Phase 2
Cultivated access, deal by deal.
Join the structured LP cultivation program — no capital ask today; first-look positioning when SPV sponsorship activates.
“CHIPS funded the infrastructure. The market has to fund what comes next.”
Jeron Peoples · President & CEO, Proving Ground Capital